Uroalerts Men's Health Weekly

Prostate Cancer

Performance of PSMA-PET/CT as verified by bone biopsy for diagnosing osseous metastases of prostate cancer.

Salvage Magnetic Resonance Imaging-guided Transurethral Ultrasound Ablation for Localized Radiorecurrent Prostate Cancer.

The Role of Dynamic Contrast Enhanced Magnetic Resonance Imaging in Evaluating Prostate Adenocarcinoma: A Partially-Blinded Retrospective Study of a Prostatectomy Patient Cohort With Whole Gland Histopathology Correlation and Application of PI-RADS or TNM

Use of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography for Nodal Staging in Prostate Cancer and Tailoring of Treatment: A Continuing Conundrum.

Survival outcomes of apalutamide as a starting treatment: impact in real-world patients with metastatic hormone sensitive prostate cancer (OASIS).

Personalized Mobile App-Based Program for Preparation and Recovery After Radical Prostatectomy: Initial Evidence for Improved Outcomes From a Prospective Nonrandomized Study.

A pooled long-term follow-up after radiotherapy for prostate cancer with and without a rectal hydrogel spacer: impact of hydrogel on decline in sexual quality of life.

Preclinical Evaluation of Bavdegalutamide (ARV-110), a Novel PROteolysis TArgeting Chimera Androgen Receptor Degrader.

Medication Prescription Policy for US Veterans With Metastatic Castration-Resistant Prostate Cancer: Causal Machine Learning Approach.

Comparative analysis of gut microbiota in hormone-sensitive and castration-resistant prostate cancer in Japanese men.

PGC-1α drives small cell neuroendocrine cancer progression toward an ASCL1-expressing subtype with increased mitochondrial capacity.

HRS Improves Active Surveillance for Prostate Cancer by Timely Identification of Progression.

Optimal Treatment Strategies for Hormone-sensitive Metastatic Prostate Cancer: Does Local Radiotherapy Play a Role in High-volume Disease?

Multiparametric MRI targeted prostate biopsy: When omit systematic biopsy?

Management strategies for radio-recurrent prostate cancer: a comprehensive review.

Landscape and prognostic significance of oncogene drivers in metastatic castration sensitive prostate cancer.

Patient-reported functional outcomes and treatment-related regret in Hispanic and Spanish-speaking men following prostate cancer treatment.

Navigating Focal Therapy for Prostate Cancer: Contemporary Perspectives and Future Trajectories in the Canadian Context.

Perioperative outcomes, environmental impact and economic implications of pelvic drain discontinuation in prostate cancer patients undergoing robot-assisted radical prostatectomy.

Development and Validation of Prognostic Model for Metastatic Castration-Resistant Prostate Cancer Patients Treated With First-Line Abiraterone or Enzalutamide.

Stereotactic body radiotherapy as metastasis-directed therapy in oligometastatic prostate cancer: a systematic review and meta-analysis of randomized controlled trials.

Circulating tumor DNA-guided treatment decision in metastatic castration-resistant prostate cancer patients: a cost-effectiveness analysis.

Improved prognosis of de novo metastatic prostate cancer after an introduction of life-prolonging agents for castration-resistant prostate cancer.

The Challenge of External Generalisability: Insights from the Bicentric Validation of a [68Ga]Ga-PSMA-11 PET Based Radiomics Signature for Primary Prostate Cancer Characterisation Using Histopathology as Reference.

A Pilot Study of PSMA PET/CT and MRI Fusion for Prostate Cancer: Software to Replace PET/MRI Hardware.

Administration and cancer-control outcomes of bone-modifying agents in real-world patients with metastatic castration-resistant prostate cancer.

Prediagnostic Plasma Nutrimetabolomics and Prostate Cancer Risk: A Nested Case-Control Analysis Within the EPIC Study.

Masked Image Modeling Meets Self-Distillation: A Transformer-Based Prostate Gland Segmentation Framework for Pathology Slides.

Genitourinary Cancer Care in Low- and Middle-Income Countries: Disparities in Incidence and Access to Care

Prostate-specific antigen kinetics in Asian patients with metastatic castration-sensitive prostate cancer treated with apalutamide in the TITAN trial: A post hoc analysis.

Canonical androgen response element motifs are tumor suppressive regulatory elements in the prostate.

Oncological Safety of MRI-Informed Biopsy Decision-Making in Men With Suspected Prostate Cancer.

High Omega-3, Low Omega-6 Diet With Fish Oil for Men With Prostate Cancer on Active Surveillance: The CAPFISH-3 Randomized Clinical Trial.

Five-year outcomes of moderately hypofractionated proton therapy incorporating elective pelvic nodal irradiation for high-risk prostate cancer.

Patient preferences for life expectancy cutoffs for aggressive treatment in clinically localized prostate cancer.

Prognostic Expression Signature of RB1, PTEN, and TP53 Genes in Patients with Metastatic Hormone-sensitive Prostate Cancer Treated with Androgen Receptor Pathway Inhibitors - Beyond the Abstract

Prostate-Specific Antigen at 3 Months as a Predictor of Radiologic Progression-Free Survival in Metastatic Hormone-Sensitive Prostate Cancer Treated with Apalutamide: Analysis of 633 Patients in a Real-World Database - Beyond the Abstract

Oncologic Outcomes of Incidental Versus Biopsy-Diagnosed Grade Group 1 Prostate Cancer: A Multi-Institutional Study - Beyond the Abstract

The Rapidly Evolving Treatment Landscape of Metastatic Hormone-Sensitive Prostate Cancer - Beyond the Abstract

Adiposity and Muscle Strength in Men With Prostate Cancer and Cardiovascular Outcomes - Beyond the Abstract

Uroalerts Men's Health Weekly

Male Infertility

Peyronie's Disease

Erectile Dysfunction

BPH - Benign Prostatic Enlargement

Penile & Urethral Cancers

Testicular Cancer

Prostate Cancer

Uroalerts Men's Health Weekly

Male Infertility

Peyronie's Disease

Erectile Dysfunction

BPH - Benign Prostatic Enlargement

Penile & Urethral Cancers

Testicular Cancer

Prostate Cancer

Login